Increlex 40 mg/4mL
mecasermin · INJECTION, SOLUTION · Ipsen Biopharmaceuticals, Inc.
No Recall History
Plain English
Increlex is a injection, solution containing mecasermin at 40 mg/4mL, taken subcutaneous. Manufactured by Ipsen Biopharmaceuticals, Inc..
Key Facts
- Brand Name
- Increlex
- Generic Name
- mecasermin
- NDC Code (Product)
15054-1040- Manufacturer
- Ipsen Biopharmaceuticals, Inc.
- Strength
- 40 mg/4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021839
- Marketing Start
- 01/03/2006
Recall History
No Recall HistoryFrequently Asked Questions
What is Increlex used for?
Increlex contains mecasermin. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Increlex a controlled substance?
Increlex is not classified as a controlled substance by the DEA.
What is the generic name for Increlex?
The generic name for Increlex is mecasermin. There are no other listed brand versions of mecasermin.
What is the NDC code for Increlex 40 mg/4mL?
The NDC (National Drug Code) for Increlex 40 mg/4mL is 15054-1040, listed by Ipsen Biopharmaceuticals, Inc..
Other Increlex Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)